Intramyocardial Injection of Autologous Bone Marrow-Derived Ex Vivo Expanded Mesenchymal Stem Cells in Acute Myocardial Infarction Patients is Feasible and Safe up to 5 Years of Follow-up

In experimental studies, mesenchymal stem cell (MSC) transplantation in acute myocardial infarction (AMI) models has been associated with enhanced neovascularization and myogenesis. Clinical data however, are scarce. Therefore, the present study evaluates the safety and feasibility of intramyocardia...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodrigo, Sander F., van Ramshorst, Jan, Hoogslag, Georgette E., Boden, Helèn, Velders, Matthijs A., Cannegieter, Suzanne C., Roelofs, Helene, Al Younis, Imad, Dibbets-Schneider, Petra, Fibbe, Willem E., Zwaginga, Jaap Jan, Bax, Jeroen J., Schalij, Martin J., Beeres, Saskia L., Atsma, Douwe E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2013
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3790917/
https://www.ncbi.nlm.nih.gov/pubmed/23982478
http://dx.doi.org/10.1007/s12265-013-9507-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3790917/
https://www.ncbi.nlm.nih.gov/pubmed/23982478
http://dx.doi.org/10.1007/s12265-013-9507-7

Ejemplares similares